5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.02▲ | 9.02▲ | 9.03▲ | 8.89▲ | 8.42▲ |
MA10 | 8.98▲ | 9.04▲ | 9.12▼ | 9.07▼ | 8.56▲ |
MA20 | 9.00▲ | 9.14▼ | 9.06▲ | 8.37▲ | 10.44▼ |
MA50 | 9.04▲ | 8.97▲ | 8.88▲ | 8.50▲ | 10.91▼ |
MA100 | 9.14▼ | 8.95▲ | 8.76▲ | 10.60▼ | 11.69▼ |
MA200 | 8.98▲ | 8.65▲ | 8.25▲ | 10.53▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.015▲ | -0.027▼ | -0.018▼ | 0.117▲ | -0.155▼ |
RSI | 57.142▲ | 50.491▲ | 52.700▲ | 55.424▲ | 45.239▼ |
STOCH | 93.073▲ | 35.182 | 23.750 | 47.358 | 36.201 |
WILL %R | -10.000▲ | -61.702 | -55.769 | -34.926 | -74.757 |
CCI | 142.693▲ | -39.182 | -60.931 | 31.452 | -20.406 |
CDL | $LUNG Harami Candlestick Pattern Detected | Set Alert |
Thursday, May 16, 2024 04:09 PM
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung cancer ...
|
Thursday, May 16, 2024 03:46 PM
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung ...
|
Thursday, May 16, 2024 12:40 PM
The U.S. FDA has approved Amgen's (AMGN) targeted cancer therapy, Imdelltra, for advanced small cell lung cancer. Read more here.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 9.28 | 9.28 | 8.88 | 9.06 | 171,314 |
15/05/24 | 9.02 | 9.35 | 8.80 | 9.32 | 266,215 |
14/05/24 | 8.87 | 9.20 | 8.73 | 8.91 | 201,321 |
13/05/24 | 8.75 | 8.85 | 8.60 | 8.77 | 207,937 |
10/05/24 | 8.77 | 8.90 | 8.28 | 8.41 | 294,382 |
09/05/24 | 8.76 | 9.05 | 8.72 | 8.75 | 586,871 |
08/05/24 | 9.33 | 9.46 | 8.78 | 8.81 | 1,130,188 |
07/05/24 | 9.29 | 9.74 | 9.29 | 9.53 | 215,882 |
06/05/24 | 9.88 | 10.01 | 9.23 | 9.28 | 356,754 |
03/05/24 | 9.55 | 9.8899 | 9.55 | 9.82 | 999,827 |
|
|
||||
|
|
||||
|
|